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Abstract 
 
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription 
factors belonging to the nuclear hormone receptor superfamily that function as critical 
regulators of lipid and energy homeostasis. Although intensively studied in mammals, 
their basic biological functions are still poorly understood. The objective of this work was 
to characterise PPARβ subtypes in a fish the Atlantic salmon (Salmo salar) in order to 
address PPAR function and the regulation of lipid homeostasis in lower vertebrates. The 
screening of an Atlantic salmon genomic library revealed the presence of four genes for 
PPARβ subtypes. Based on comparisons of exons and exon-flanking regions, these genes 
were assigned into two families, ssPPARβ1 and ssPPARβ2, each family containing two 
isotypes; ssPPARβ1A and β1B and ssPPARβ2A and β2B. Two full-length cDNAs for 
ssPPARβ1A and ssPPPARβ2A were isolated. Transcripts for ssPPARβ1A and 
ssPPARβ2A have distinct tissue expression profiles, with ssPPARβ1A predominating in 
liver and ssPPARβ2A predominating in gill. Expression levels of mRNA of either isotype 
were up to ten fold lower in kidney, heart, spleen, muscle, and brain.. In cellular 
transfection assays ssPPARβ1A is activated by monounsaturated fatty acids, 2-
bromopalmitate and by the mammalian PPARβ-specific ligand GW501516. In contrast, 
PPARβ2A was not activated by any of the compounds tested. Furthermore, ssPPARβ2A 
repressed both basal reporter gene activity and the GW501516-induced activity of 
ssPPARβ1A. The results indicate unexpected levels of variety and complexity in PPAR 
subtype and mechanism of action in lower vertebrates. 
 
Footnote: The sequences referred to have been deposited in the EMBL/NCBI databases 
under accession numbers AM229297 to AM229306. 
 
Abbreviations: CAT, chloramphenicolacetyltransferase; FBS, fetal bovine serum; PBS, 
phosphate buffered saline; ONPG, 0-nitrophenolgalactoside; LBD, ligand binding 
domain; NHR, nuclear hormone receptor; nt, nucleotide: PPAR, peroxisome proliferator-
activated receptor; PPRE, PPAR response elements; QPCR, quantitative PCR; RACE, 
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rapid amplification of cDNA ends; RNase, ribonuclease; AS, Atlantic salmon; SMART, 
switching mechanism at 5’ end of RNA transcript. 
 
 
Introduction 
 
Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription 
factors that belong to the nuclear hormone receptor superfamily. Originally isolated from 
humans, rodents and amphibians, they are now widely accepted to be critical regulators 
of lipid and energy homeostasis (Isseman and Green, 1990; Krey et al, 1993; Desvergne 
and Wahli, 1999; Hihi et al., 2002). In mammals, one gene for each of three PPAR 
subtypes, PPARα, PPARβ (also known as PPARδ) and PPARγ is present (Michalik and 
Wahli, 1999). The role of PPARα is hypothesised to be primarily in controlling the 
reversible induction of β-oxidation in specific tissues, especially liver, as a response to 
changing energy requirements and nutritional status. The evidence for this comes most 
directly from rodents where PPARα is expressed in cells with high catabolic rates of fatty 
acid oxidation such as hepatocytes, cardiomyocytes, kidney proximal tubules and 
intestinal mucosa (Escher et al., 2001). Indeed, PPARα-null mice are incapable of up-
regulating fatty acid oxidation during fasting (Kersten et al., 1999; Leone et al, 1999). In 
contrast, mammalian PPARγ is considered to play a critical role in fat accumulation 
particularly in adipocytes, and in lipid-accumulating macrophages (Rosen and 
Speigelman, 2001). The role of PPARβ is less well understood. Various studies suggest 
that PPARβ has a role in global control of lipid homeostasis in mammals. It is moderately 
activated by a range of unsaturated fatty acids (Forman et al., 1997) and has a broad 
tissue expression profile (Escher at al, 2001). PPARβ-null mice show reduced adipose 
stores (Peters et al., 2000) which cannot be explained by adipose-specific PPARβ 
deficiency (Barak et al., 2002; Wang et al., 2003). Furthermore, in the absence of ligand, 
PPARβ can act as a repressor of PPARα and PPARγ action (Shi et al., 2002). Similarly in 
cell overexpression systems and in the absence of activating ligand, PPARβ can down-
regulate genes involved in lipid and energy metabolism (Tachibana et al., 2005). Recently 
highly specific and potent synthetic ligands for mammalian PPARβ have been developed. 
Treatment of animals with these compounds has demonstrated that ligand-activated 
PPARβ directly controls lipid utilisation through up-regulation of genes involved in β-
oxidation and energy uncoupling in various tissues (Dressel et al., 2003, Tanaka et al., 
2003; Wang et al., 2003, Tachibana et al., 2005). In consequence PPARβ ligands can 
have beneficial effects in correcting dyslipodemic states in various animal disease 
models. Thus, PPARβ ligands are now receiving considerable attention as potential 
pharmaceuticals for the treatment of a variety of human diseases associated with 
dyslipidemia (Desvergne et al., 2004).  
In addition to functioning as a regulator of energy metabolism PPARβ has also been 
shown to have significant roles in the control of cellular proliferaton and differentiation. 
Studies on PPARβ-null mice have indicated the PPARβ functions in skin wound healing 
(Michalik et al, 2001), keratinocyte differentiation (Schmuth et al, 2004; Kim et al., 
2006) in apoptosis (Di Poi et al., 2002) and in skin and colon carcinogenesis (Harman et 
al., 2004; Kim et al., 2004) 
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Despite these developments bona fide endogenous ligands for PPARβ have still not been 
conclusively defined and the precise role of PPARβ in lipid and energy metabolism, and 
how this relates to PPARβ function in cellular differentiation and proliferation, is not yet 
understood. The study of PPARs in lower vertebrates such as fish offers an opportunity to 
compare expression, to define common ligands and infer common functions across 
vertebrates, thus informing studies on PPARs in humans. Recently a study on two 
members of a major fish clade, the Perciformes, reported the identification and 
characterisation of homologues of PPARα, β and γ (Leaver et al., 2005). Comparison of 
these gene sequences with information from the pufferfish (Takafugu rubriprides and 
Tetraoadon nigrviridis, also Perciformes) genome sequencing projects suggested that 
these fish possessed a single PPARβ gene and that it shared many of the features of its 
mammalian counterpart. However, examination of the zebrafish genome database 
indicated that there are two PPARβ genes in this Cypriniform species. Consequently, the 
exact number of genes and/or the presence of distinct PPAR isoforms in fish have yet to 
be determined. Here we show that multiple PPARβ genes are present in Atlantic salmon, 
a commercially important member of a third major fish clade, the Salmoniformes. Two of 
these gene products are demonstrated to differ in tissue expression profile and 
transactivation properties.  
 
Materials and Methods 
 
Isolation of Atlantic salmon PPAR genes 
 
An Atlantic salmon genomic DNA library was constructed in λFIXII (Stratagene, La 
Jolla, CA) from DNA isolated from blood from a single individual. This library was 
screened with a 32P labelled DNA probe corresponding to the ligand-binding domain 
(LBD) of plaice (Pleuronectes platessa) PPARβ (Leaver et al., 2005). Hybridising clones 
were isolated, phage DNA purified, restriction digested and subjected to Southern blot 
analysis using the plaice PPARβ probe. Hybridising restriction fragments were then 
subcloned to plasmid vectors and sequenced using an ABI 477 autosequencer and 
BigDye sequencing reagents. Sequences were analysed using Autoassembler software 
supplied by ABI. 
 
Isolation of Atlantic salmon PPARβ cDNAs 
 
Full length cDNAs were isolated from total salmon liver RNA using reverse 
transcription, PCR and RACE (SMART RACE system, BD Clontech, Oxford, UK). 
Gene specific primers (P1, P2, P3; Fig 1., Table 1) were directed to the regions 
immediately adjacent to PPARβ termination codons predicted from genomic sequencing. 
These primers were combined in 5’RACE PCR reactions with SMART liver cDNA and 
the SMART system universal primer. Further RACE PCR was performed with primers 
synthesised to specific regions within products arising from the first round of reactions. 
These primers (P4, P5; Fig 1., Table 1) were used in nested PCR procedures. Finally full 
length open reading frames for salmon PPARβ cDNAs were obtained using both forward 
and reverse gene specific primers (P1, P6, P7, P8; Fig 1,. Table1.), designed from 
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consideration of the previously isolated RACE products. All products were ligated to E. 
coli plasmid vectors and sequenced. 
 
Table 1. Oligonucleotide primers used for Atlantic salmon PPARβ cDNA isolation 
 
Primer Oligonucleotide 5’ to 3’ 
P1 TAAACCAGTCCAGTCAGTACATGTCC 
P2 CAGTCAGTACATGTCCTTATAGATC 
P3 TTCCAGTCAGTACAGATTTAGTCCGGT 
P4 CTTGGGGAAGACATAGAGGGAGTCCTG 
P5 TCGTTAAGGAAGAGATCCACAAACCCT 
P6 CAGGATCCATGGGTAGCCAACAGAATGGAGAGATTG 
P7 AAGGTACCAGTCAGTACATGTCCTTATAGATCTCCT 
P8 CTTGGATCCTGGGACATGAAG 
 
Tissue Expression 
 
Total RNA was isolated from tissues of three Atlantic salmon (average mass = 200g) 
using TriReagent (Sigma, Poole, UK). For QPCR (quantitative PCR) 1µg of total RNA 
were converted to cDNA using a blend of poly-dT oligonucleotide primer (25nM) and 
random hexamers (75nM), and Reverse-iT reverse transcriptase (AMV/MMuLV blend; 
ABgene, Epsom UK). QPCR reactions of 20µl contained 100nM each primer, cDNA 
from the equivalent of 25ng total RNA for PPARβ reactions and from the equivalent of 
0.25ng RNA for 18S rRNA reactions. Amplicons were quantified using SYBR Green 
PCR mastermix (Abgene, Epsom, UK) and a Techne Quantica QPCR instrument. 
Cycling parameters consisted of a 15 min 95°C soak to activate the polymerase followed 
by 40 cycles of 95°C for 15 secs and 60°C for 1 minute. Primers were directed to areas 
where the two cDNAs exhibited low nucleotide identity, either side of the junction 
corresponding to the first exon of the LBD of each PPAR. For PPARβ1A these were 5’-
GACCACCAACCCCAATGGCTCGGAT and 5’-CAGCCCATTCTCAGCCTGGCACAAG, and for 
PPARβ2A, 5’-CCCCCACCATCTTGGTGGCTCAGA and 5’-
TAGACCACTCTCTGCTTGCCACAGG. The PCR products produced from these primers 
under QPCR conditions were checked by gel electrophoresis and sequencing before 
undertaking QPCR. In each case the predicted products of 176 base pairs and 190 base 
pairs for PPARβ1A and PPARβ2A respectively were amplified. Values for PPARβ were 
normalised to 18SrRNA levels measured with primers: 5’-
CTGCCCTATCAACTTTCGATGGTACT and 5’-AAAGTGTACTCATTCCAATTACGGGG. 
 
Cell Transfection Experiments 
 
Salmon PPARβ cDNAs were ligated to pcDNA3 and used to transfect AS (derived from 
Atlantic salmon, epitheloid: Nicholson and Byrne, 1973) cells with pCMVβgal and a 
reporter construct containing a PPRE from the mouse cyp4A6 promoter (Ijpenberg et al., 
1997) linked to a chloramphenicol acetyltransferase (CAT) gene. AS cells were routinely 
grown and passaged in DMEM, 10% FBS. Prior to transfection cells were passaged into 
DMEM, plus charcoal/dextran-stripped 10% FBS (Pierce, Rockford, IL ). 1.5µg of total 
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plasmid DNA were transfected to each well of 12 well tissue culture plates using 7.5µl of 
Superfect reagent according to the manufacturers instructions (Qiagen, Crawley, UK). 
Twenty four hours after transfection cells were treated with fatty acids (100µM, Sigma, 
Poole, UK), Wy16463 (50µM), rosiglitazone, GW501516 (10µM, Alexis Corporation, 
UK), and L165041 (10µM, Calbiochem) in 5µl ethanol. Cells were harvested 24 hours 
after treatment, lysed in 300 µl of detergent-based buffer and CAT protein was measured 
using an ELISA method (Roche, Lewes, UK). β-galactosidase activity was measured in a 
microtitre plate based assay. Briefly 20µl of cell lysate was incubated with 130µl of PBS 
containing 5mM MgCl2, 10mM β-mercaptoethanol, 1.5mM ONPG. After 30mins the 
reaction was stopped by the addition of 75µl of 1M Na2CO3 and the A420 measured. CAT 
quantity was normalised to β-galactosidase activity and, after subtracting mock-
transfected blank values, values for each treatment were expressed relative to the ethanol 
control for pcDNA3 (empty vector). All treatments were performed in triplicate. 
 
Results 
 
Atlantic salmon possess four distinct PPARβ genes 
 
The salmon genomic library was screened with a probe corresponding to the LBD of a 
plaice PPARβ (Leaver et al., 2005) and a total of nine distinct phage inserts were found 
to contain PPARβ-related sequences. Assembly of the sequences from these nine inserts 
produced four distinct clone sets, each comprised of overlapping genomic fragments.  
Comparisons of exon sequences corresponding to the LBD of PPARβ suggested that they 
contained distinct sequences. Based on the genomic sequence information, 
oligonucleotide primers were designed to be specific for each PPARβ sequence. Initially 
primers were directed to the regions adjacent to the termination codons of each of three 
gene sequences (Fig 1; L1, L29 and L92 clone sets). For the L1 clone set a single cDNA 
was isolated (designated ssPPARβ1A) which was found to contain a full-length open 
reading frame for PPARβ.  For L92 a partial cDNA was obtained containing only the 
coding region corresponding to the LBD of PPARβ. This cDNA was distinct from 
ssPPARβ1A. No PPARβ cDNAs were obtained for the L29 clone set (designated as 
ssPPARβ1B). Using the partial cDNA sequence derived from the L92 clone set, two 
more oligonucleotides were designed to areas within the region corresponding to the 
LBD. These were used in a nested 5’-RACE procedure and two distinct cDNAs were 
obtained. One of these cDNAs contained an open reading frame for a PPARβ isoform 
distinct from both ssPPARβ1A and the partial L92 cDNA, and was designated 
ssPPARβ2A (corresponding to the L6 clone set). The other cDNA corresponded, with 
100% nucleotide identity in the overlapping region, to the previously isolated partial L92 
cDNA. This cDNA contained an open reading frame which lacked a DNA-binding 
domain but possessed an intact A/B domain and LBD and together with the gene in the 
L92 clone set was designated ssPPARβ2B. The gene and cDNA sequences corresponding 
to the exons encoding the LBD of each of the presumed PPARβ genes were aligned, 
together with exon flanking regions (Fig 2.). The percentage identity matrices for these 
alignments showed that one of the cDNA sequences (sPPARβ1A) was identical to the 
gene present in the L1 clone set. The other full length cDNA (sPPARβ2A) showed 
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between 98% and 100% identity to clone set L6, whilst the atypical sPPARβ2B cDNA 
showed between 99 and 100% identity to the L92 clone set. Further attempts were made 
to isolate a cDNA (ssPPARβ1B) corresponding to the L29 genomic sequence from gill, 
kidney and muscle cDNA but were unsuccessful. It should be noted that the materials for 
the construction of genomic and cDNA libraries were derived from different individuals, 
thus the small differences observed between these cDNAs and genes are most likely the 
result of allelic variation within salmon populations. Also apparent from the identity 
matrices is that the clone sets fall into two groups of two genes each, with about 80% 
identity between members from different groups. Exon flanking sequences from the 
genes were compared to determine whether the four genes were from distinct loci, or 
were allelic variants from two loci. From Fig 2., it is apparent that, although there is some 
similarity in the exon flanking regions between L29 and L1, and between L6 and L92 
clone sets, there is a lower level of identity than might be expected of allelic variants. 
This indicates that there are at least four distinct PPARβ genes in salmon. 
 
 
 
Figure 1. Schematic representation of Atlantic Salmon PPARβ genes and cDNAs. 
L1, L29, L6 and L92 are overlapping phage insert sets and the exons present are indicated as open boxes. 
ssPPARβ1A, β2A and β2B are the cDNAs isolated using the primers P1 to P8 (see text), with the open 
reading frames indicated by open boxes. The ssPPARβ1B cDNA, corresponding to insert set L29 was not 
isolated. The diagram is not to scale. 
 
Atlantic salmon PPARβ phylogeny  
 
Comparison of the deduced amino acid sequences of the full-length ssPPARβ1A and 
ssPPARβ2A cDNAs clearly demonstrated that both salmon PPARs phylogenetically 
clustered with PPARβ subtypes from diverse vertebrates (Fig 3). The salmon PPARs 
were most closely related to PPARs from other fish species. However, it is notable that, 
within the PPARβ phylogeny, the two zebrafish PPARβ isoforms do not resolve on the 
same branches as the salmon isoforms, and in any case their positions in the phylogeny 
are not well supported by bootstrap values. Most amino acid identity between the salmon 
isoforms and PPARβ from other vertebrates was evident in the DNA-binding and ligand–
binding regions, although there were also areas of cross-species identity in both the AB-
domain and D-domain (Fig 4). In both ssPPARβ1A and ssPPARβ2A the amino acid 
residues which interact with fatty acid ligand and with co-activator proteins are 
conserved. (Nolte et al., 1998; Xu et al., 1999; Fyffe et al., 2006, Fig 4). 
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Figure 2. Identity matrices and exon flanking regions of Atlantic salmon PPARβ genes and cDNAs 
comprising the region corresponding to the ligand-binding domain. 
Numbers indicate the percentage identity between pairs of sequences. L1, L6, L29 and L92 are the gene 
sequences (boxed). The flanking exon sequences are shown with the AG/GT splice junctions and TGA 
termination codons underlined. β1A, β2A and β2B are the ssPPARβ cDNA sequences. 
 
 
Differential tissue expression of salmon PPARβ genes 
 
QPCR analysis of salmon PPARβ expression across a range of tissues indicated that there 
were differences in relative expression levels (Fig 5). SsPPARβ1A was most highly 
expressed in liver and adipose, whilst ssPPARβ2A was most highly expressed in gill and 
adipose. The levels of ssPPARβ1A exceeded those of ssPPARβ2A in liver. In gill 
PPARβ2A was the predominant isoform and both were expressed equally in adipose. The 
expression levels in other tissues were 3 to 5 fold lower than in liver, gill and adipose and 
there were no differences between the expression level of PPARβ1A and ssPPARβ2A. 
 
Differential transactivation of salmon PPARβ subtypes  
 
In cellular transfection assays (Fig. 6) there was a relatively small but significant 
activation of ssPPARβ1A by palmitoleic acid. In contrast there was no apparent effect of 
oleic, linolenic, arachidonic, eicosapentenoic or docosahexaenoic acids.  There was a 
much greater response to the mammalian PPARβ-specific ligand GW501516 and to 
bromo-palmitate. However L165041, another mammalian PPARβ-selective ligand, was 
not an effective activator of salmon ssPPARβ1Α. Note that all compounds that resulted in  
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Figure 3. Phylogenetic tree for the ligand 
binding domain (LBD) of PPARs from diverse 
species.  
The deduced amino acid sequences corresponding 
to the LBD of the PPAR isotypes from plaice (pp), 
Atlantic salmon (ss), human (hs),  and zebrafish 
(dr) were aligned using ClustalW and the resulting 
data used to construct an unrooted tree using 
Bayesian inference (MrBayes 3; Ronquist & 
Huelsenbeck, 2005). The tree was plotted with 
NJplot. Confidence values of branch topologies are 
indicated. 
 
 
 
 
 
 
 
 
 
the activation of ssPPARβ1A also induced the basal activity of the reporter construct 
suggesting the presence of endogenous ssPPARβ1A. Indeed, QPCR indicated that 
ssPPARβ1A was present (not shown) in the AS cell line although at lower levels per unit 
input RNA than any of the salmon tissues tested. This may indicate that fatty acids are 
effective activators of ssPPARβ1A, since they all induced reporter gene activity 
significantly above that induced by the vehicle ethanol. Transfection of the ssPPARβ2A 
significantly reduced the basal level of transcription from the reporter construct with all 
tested compounds (Fig 6), suggesting repression of endogenous ssPPARβ1A activity in 
the AS cell line. To test this AS cells were transfected with both ssPPARβA1 and 
ssPPARβ2A and reporter gene activation measured after GW501516 treatment. The 
results confirmed (Fig 7) that ssPPARβ2A repressed both the basal and GW501516-
induced activity of ssPPARβ1A as well as the endogenous basal and induced activity.  
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Figure 4. Comparison of PPARβ from Atlantic salmon, plaice and human  
Alignment was generated with ClustalW and identical residues present in 3 or more of the four sequences 
are shaded. The functional domains of the proteins are indicated by shaded or unshaded, labeled boxes 
below the sequence line. The positions of residues which are not conserved in ssPPARβ2A are highlighted. 
Residues involved in human PPARβ ligand binding are boxed and shaded. Residues involved in human 
PPAR co-activator binding are boxed and unshaded. 
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Figure 5. Tissue expression profile of Atlantic 
salmon PPARβ isotypes 
Results of QPCR assays as described in text. 
Data represents mean + SD from three individual 
salmon. PPARβ was normalised to 18S RNA. 
Both genes were quantified by comparison with a 
standard curve of linearised plasmid containing 
the corresponding insert cDNA. Asterisks 
indicate tissues in which one of the PPAR 
subtypes significantly (P<0.05; t-test) differs 
from the other. 
 
 
 
 
 
 
 
Figure 6. Transactivation of Atlantic salmon PPARβ 
AS cells were transfected with the expression vector pcDNA3, alone (cDNA3) or containing the coding 
sequences for the two Atlantic salmon PPARs, a CAT reporter construct containing the Cyp4A6-Z PPRE 
and a β-galactosidase expression plasmid. Cells were treated with 100µM palmitoleic acid (16=1), oleic 
acid (18=1), linolenic acid (18=3), arachidonic acid (20=4), eicosapentenoic acid (20=5), docosahexenoic 
acid (22=6), 50µM 2-bromopalmitate (BR16) 50µM Wy-14,643 (WY) 10µM L165041 (L), 10µM 
GW501516 (GW), 10µM rosiglitazone (ROS) or the vehicle ethanol (EtOH). Results are expressed as the 
fold increase in CAT (after subtraction of mock transfected background and normalisation to β-
galactosidase) with respect to the ethanol control values for empty vector (pcDNA3). Figures represent a 
single experiment out of two repetitions and all treatments were in triplicate. Error bars correspond to 
standard deviations of the mean. 
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Discussion 
 
Atlantic salmon are both a declining wild species with a complex and characteristic life 
cycle, and a commercially valuable farmed species. The management of both wild and 
farmed stocks is as rich in social, economic and political issues as its resource base is rich 
biologically. However a particular biological problem which concerns both the survival 
of wild fish and the quality of farmed fish is related to the control of energy and 
particularly lipid homeostasis. PPARs are now known to be critical regulators of these 
processes. The study presented here is the first report of the functional characterisation of 
PPAR subtypes from a salmonid species, the Atlantic salmon. Phylogenetic analysis 
shows that the four genes described here all belong to the PPARβ subfamily. In 
mammals, where PPARs have been studied most intensively, a single gene encodes for 
PPARβ and studies in other fish species have identified varying numbers of PPARβ 
subtypes. BLAST searches of near complete genome sequences for the pufferfishes, 
Takafugu rubripes and Tetraodon nigroviridis, reveal the presence of only one PPARβ 
gene. Similarly in plaice and sea bream it has previously been reported that only one 
PPARβ gene is detectable (Leaver et al., 2005). This compares to the situation in 
zebrafish, where, from genomic sequence and published information, there is clear 
evidence of two PPARβ isoforms (Robinson-Rechavi et al, 2001; Leaver et al., 2005). Of 
the four Atlantic salmon sequences identified here at least two appear to be functional 
genes for PPARβ (termed here ssPPARβ1A and ssPPARβ2A) as shown by the 
identification of corresponding cDNAs containing complete coding sequence. It is not 
clear whether our failure to isolate fully resolved cDNAs for the other two gene 
sequences is because that these are not functional genes or because they are not 
expressed. It is nevertheless important to note that for one of the other genes 
(ssPPARβ2B) we were able to isolate a cDNA with an open reading frame containing an 
AB-domain, a D-domain and a ligand-binding domain but lacking a DNA-binding 
domain. It is not yet clear whether this represents an aberrantly or partially processed 
mRNA or codes for an atypical but functional PPARβ subtype. For the other gene 
(ssPPARβ1B), through sequence homology, we could identify six of seven coding exons 
on a single lambda genomic clone (not shown: Acc nos AM229298 and AM229299). The 
first coding exon of ssPPARβ1B could not be definitively established because of the 
uncertainty in predicting this less conserved region of the gene by homology. 
Nevertheless, it is likely that this gene also encodes a functional PPAR. Attempts to 
isolate a cDNA for this gene from a variety of tissue were not successful suggesting that 
either it is not expressed or it is expressed in a tissue or developmentally restricted 
manner.  
The presence of four PPARβ genes in salmonids is most probably a result of a relatively 
recent polyploidisation event (60-90 million years) which is clearly evident in the 
evolution of salmonids (Allendorf and Thorgaard, 1984). Moreover more ancient 
polyploidisation events have been proposed as a driving force for the evolution of the 
vertebrate lineage (Ohno, 1970). One of these has been proposed to have occurred in the 
early evolution of ray-finned fishes (Taylor et al., 2003) and recent comparative syntenic 
analysis of zebrafish and pufferfish genomes (Woods et al., 2005) have supported this 
event and inferred subsequent lineage-specific duplications or losses to account for the 
differences in gene numbers between these species. The four PPARβ genes in Atlantic 
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salmon clearly group into two subfamilies most likely representing the polyploidization-
dependent duplication of two PPARβ subtypes from an ancestral diploid salmonid, these 
two genes arising from the more ancient ray-finned fish event. The phylogenetic analysis 
suggests that these two salmon subfamilies are not orthologous to the two PPARβ 
subtypes in zebrafish, although it should be noted that the zebrafish sequences are not 
placed in the tree with high confidence and a definitive conclusion must await functional 
characterisation of the zebrafish PPARβ subtypes.  
 
 
 
Figure 7. ssPPARβ2A represses the 
activity of ssPPARβ1A 
AS cells were transfected with cDNA3 (no 
PPAR) alone, or in combination with 
ssPPARβ1A and/or ssPPARβ2A. Cells were 
treated with GW501516 or with the vehicle, 
ethanol, as indicated. Results are expressed 
as arbitrary units of normalised CAT activity. 
Figures represent a single experiment out of 
two repetitions and all treatments were in 
triplicate. Error bars correspond to standard 
deviations of the mean.  
 
 
 
 
 
From an evolutionary perspective, a key question surrounding the process of 
polyploidizaton is how an individual with a polyploid genome would gain a selective 
advantage in a population and thence give rise to a new polyploid species. For such 
polyploidized individuals to reproduce successfully they are required to undergo a 
process of diploidization concurrent with functional divergence of duplicated loci to 
obtain a selective advantage over their diploid relatives (Wolfe, 2001). The genetic 
divergence of PPARβ subtypes in salmon may be an example of the outcome of this 
diploidization process, and as such these genes would be expected to exhibit functional 
divergence. Indeed, our results indicate that ssPPARβ1A or ssPPARβ2A are 
differentially expressed and exhibit distinct activation characteristics. Levels of 
ssPPARβ1A predominate in liver and ssPPARβ2A predominate in gill and the 
differential expression of salmon PPARβ isoforms has functional significance when the 
cellular transfection results are considered. It would appear that ssPPARβ1A is similar in 
ligand-activation profile to PPARβ from other species (Forman et al 1997; Oliver et al., 
2001; Leaver et al., 2005) being responsive to palmitoleic and oleic acids and to 2-
bromopalmitate. Importantly it is highly activated by the mammalian PPARβ-selective 
ligand GW501516, but not activated by the PPARα-specific ligand WY146463. The 
response to GW501516 suggests that, as with PPARβ in mammals, this compound is a 
ligand for ssPPARβ1A. The identification of highly selective and potent ligands for fish 
PPARs is a necessary step in advancing understanding in this area and further studies are 
required to test whether GW501516 will be as selective and potent in salmon as it is in 
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mammals. On the other hand, the lack of response of ssPPARβ2A to fatty acids or 
PPARβ-selective ligands is intriguing. Consideration of the LBD of ssPPARβ2A 
suggests that this may be because there are critical differences between the sequence of 
this isoform and the sequences of  mammalian or other characterized fish PPARβ 
homologues. A number of amino acids residues are not conserved in the ssPPARβ2A 
subtype (Fig 4) which may change the characteristics of the LBD. However, none of 
these substitutions are at positions shown to be involved in either fatty acid ligand 
binding (Xu et al, 1999; Fyffe et al., 2006) or in co-activator binding to human 
PPAR (Nolte et al, 1998), suggesting that ssPPARβ2A may be capable of binding and 
being activated by as yet undiscovered ligands. It is possible that, if the two salmon 
subtypes have conserved functions and binding specificity, the true endogenous ligand 
for vertebrate PPARβ may not be fatty acids but might in future be identified as a 
compound which activates both ssPPARβ1A and ssPPARβ2A. Alternatively, the non-
conserved substitutions or other characteristics of ssPPARβ2A may prohibit ligand-
activation under any circumstances and its sole function may be to repress the activity of 
other PPARs. Mammalian PPARβ has been shown to repress the activity of the other 
PPAR subtypes by competing for binding to PPREs (Shi et al., 2002). In this respect, the 
repressive ability of ssPPARβ2A in both basal and GW501516-induced transcriptional 
activity is significant. The high levels of expression of ssPPARβ2A in gill, in 
combination with its repressive activity, may have specific implications for the action of 
other PPAR subtypes in this tissue. As the fish gill is in close contact with the external 
environment, a single layer of epithelial cells separating the blood from the water, it is 
possible that in this tissue ssPPARβ2A functions to repress the activity of other PPARs in 
order to prevent their un-programmed activation by exogenous compounds or 
contaminants. Thus Atlantic salmon may have evolved novel PPARβ-dependent 
processes. In this regard it is important to note that other salmonids, such as rainbow trout 
and brown trout (Onchorhyncus mykiss; Salmo trutta) are also polyploid and would thus 
contain homologues of the four salmon PPARβ genes. Previous studies (Liu et al, 2005; 
Batista-Pinto et al., 2005) of tissue expression profiles and PPAR-agonist responses in 
these species have only considered a single PPARβ subtype identified from partial cDNA 
sequences. In future, and in the light of these results from salmon, such studies should be 
conducted with the expectation of the presence of multiple PPAR subtypes with divergent 
function in trout and other salmonids. 
In conclusion, these studies demonstrate the possibility for unexpected levels of variety in 
PPARβ subtype and mechanism of action in Atlantic salmon, showing that further 
complexity in physiological control may result from functional divergence of duplicated 
nuclear receptor genes. Further studies are required to understand the role of these 
important regulators of lipid homeostasis in life cycle and evolutionary adaptation in 
salmonids and to determine common PPAR-dependent processes across all vertebrates. 
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